NCT06432725 · University of Miami
Joining Under-connected Networks to Optimize "Salud" (Health) ("JUNTOS")
What this study is about
The objective of this study is to evaluate the JUNTOS Referral Network as an implementation strategy to enhance the reach of HIV-prevention and treatment services to Latino gay, bisexual, and other men who have sex with men (MSM).
View original scientific description
The objective of this study is to evaluate the JUNTOS Referral Network as an implementation strategy to enhance the reach of HIV-prevention and treatment services to Latino gay, bisexual, and other men who have sex with men (MSM).
Interventions
BEHAVIORAL
JUNTOS
HIV test counselor and Latino MSM participants will be given access to the JUNTOS website/app, which shows information about local HIV and ancillary services. HIV test counselor participants will also be given access to a training video explaining how to use the JUNTOS website/app. HIV test counselors are encouraged to use the website/app for approximately 10 minutes at least once a week when meeting with Latino MSM testing clients. Latino MSM are encouraged to use the website/app to locate HIV and ancillary services as needed.
BEHAVIORAL
Referral Sheet
HIV test counselor and Latino MSM participants will be given access to referral sheet, which is a list of local HIV and ancillary services. HIV test counselors are encouraged to use the referral sheet for approximately 10 minutes at least once a week when meeting with Latino MSM testing clients. Latino MSM are encouraged to use the referral sheet to locate HIV and ancillary services as needed.
Primary outcome measures
Use of Biomedical HIV Prevention/Treatment
Time frame: 3-months
The number of Latino MSM participants who indicated using a biomedical HIV prevention/treatment.
Percentage of Latino MSM Referral for Biomedical HIV Prevention/Treatment
Time frame: 3-months
The Referral Fidelity Questionnaire, developed for this study, has scores that range from 0% to 100%. Higher scores indicate more Latino MSM clients were referred to biomedical HIV Prevention/Treatment.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- HIV Test counselors:
- 18 years of age or older
- Certified as an HIV test counselor in Miami-Dade County or Broward County (at the time of enrollment)
- Working or volunteering as an HIV test counselor in Miami-Dade County or Broward County and report testing 2 or more Latino MSM client per month (at the time of enrollment)
- Plans to continue working or volunteering as an HIV test counselor in Miami-Dade County or Broward County for the next 6 months
- Reports suboptimal fidelity to pre-exposure prophylaxis (PrEP) referral guidelines (\<90% fidelity) and/or self-reports an unmet need for HIV prevention/treatment referral resources Latino MSM:
- 18 years of age or older
- Identifies as Latino/a/x or Hispanic
- Identifies as a sexual minority man or reports being a man who has sex with men
- Speaks English and/or Spanish
- Received a diagnostic HIV test from an HIV test counselor participating in the study or completed a diagnostic HIV test with a counselor in the last 3 months
- Lives in Miami-Dade County, Broward County, or Palm Beach County and anticipates living there for the next three months
Exclusion criteria
- HIV test counselors:
- Unable to consent
- Study personnel unable to verify HIV test counselor role in Miami-Dade County or Broward County (e.g., confirmation of where they work/volunteer as HIV test counselor, location they state they provide services doesn't exist or does not provide HIV testing services)
- Works as an HIV test counselor in an incarceration/prison setting (i.e., clients are prisoners) Latino MSM:
- Unable to consent
Where
- Coral Gables, Florida
Collaborators
National Institute of Mental Health (NIMH)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 22, 2026 · Source of record for eligibility and locations